Last updated on May 2019

Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia

Brief description of study

The purpose of the study is to evaluate the efficacy, safety, and tolerability of different dose regimens of TV-46000 administered subcutaneously as compared to placebo during maintenance treatment in adult and adolescent patients with schizophrenia. The study will include male and female patients, 13 to 65 years of age, who have a confirmed diagnosis of schizophrenia, are clinically stable, and are eligible for risperidone treatment.

Clinical Study Identifier: NCT03503318

Find a site near you

Start Over

Teva Investigational Site 14815

Pico Rivera, CA United States
  Connect »

Teva Investigational Site 14803

Norwalk, CA United States
  Connect »

Teva Investigational Site 14794

Bellflower, CA United States
  Connect »

Teva Investigational Site 14817

La Habra, CA United States
  Connect »